Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
106
mi
from 91732
San Diego, CA
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
106
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
2322
mi
from 91732
Miami, FL
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
2322
mi
from 91732
Miami, FL
Click here to add this to my saved trials
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
1900
mi
from 91732
Newnan, GA
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
1900
mi
from 91732
Newnan, GA
Click here to add this to my saved trials
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
1610
mi
from 91732
Arlington Heights, IL
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
1610
mi
from 91732
Arlington Heights, IL
Click here to add this to my saved trials
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
1792
mi
from 91732
Indianapolis, IN
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
1792
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
1779
mi
from 91732
Plainfield, IN
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
1779
mi
from 91732
Plainfield, IN
Click here to add this to my saved trials
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
1968
mi
from 91732
Warren, MI
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
1968
mi
from 91732
Warren, MI
Click here to add this to my saved trials
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
1512
mi
from 91732
Fridley, MN
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
1512
mi
from 91732
Fridley, MN
Click here to add this to my saved trials
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
2351
mi
from 91732
New York, NY
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
2351
mi
from 91732
New York, NY
Click here to add this to my saved trials
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
2372
mi
from 91732
Fort Washington, PA
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
2372
mi
from 91732
Fort Washington, PA
Click here to add this to my saved trials
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
2031
mi
from 91732
Fountain Inn, SC
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
2031
mi
from 91732
Fountain Inn, SC
Click here to add this to my saved trials
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
1212
mi
from 91732
Austin, TX
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
1212
mi
from 91732
Austin, TX
Click here to add this to my saved trials
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
1188
mi
from 91732
San Antonio, TX
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
1188
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated:  12/31/1969
Aclaris Investigational Site
2365
mi
from 91732
Broomall, PA
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
2365
mi
from 91732
Broomall, PA
Click here to add this to my saved trials
Study of Leukocyte Interleukin, Injection for Treatment of Perianal Warts
Phase 1 Dose Escalation Study to Establish the Safety of Leukocyte Interleukin, Injection for Treatment of Perianal Warts in Adult Men and Women Who Are HIV/HPV Co-infected
Status: Enrolling
Updated:  12/31/1969
Naval Medical Center - San Diego
117
mi
from 91732
San Diego, CA
Study of Leukocyte Interleukin, Injection for Treatment of Perianal Warts
Phase 1 Dose Escalation Study to Establish the Safety of Leukocyte Interleukin, Injection for Treatment of Perianal Warts in Adult Men and Women Who Are HIV/HPV Co-infected
Status: Enrolling
Updated: 12/31/1969
Naval Medical Center - San Diego
117
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Study of Leukocyte Interleukin, Injection for Treatment of Perianal Warts
Phase 1 Dose Escalation Study to Establish the Safety of Leukocyte Interleukin, Injection for Treatment of Perianal Warts in Adult Men and Women Who Are HIV/HPV Co-infected
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
356
mi
from 91732
San Francisco, CA
Study of Leukocyte Interleukin, Injection for Treatment of Perianal Warts
Phase 1 Dose Escalation Study to Establish the Safety of Leukocyte Interleukin, Injection for Treatment of Perianal Warts in Adult Men and Women Who Are HIV/HPV Co-infected
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
356
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
Do NSAIDS or Executing Exercise Decrease Local Erythema, Site Swelling & Pain After INoculation
"Do NSAIDS or Executing Exercise Decrease Local Erythema, Site Swelling & Pain After INoculation: the NEED LESS PAIN Study"
Status: Enrolling
Updated:  12/31/1969
Womack Army Medical Center
2205
mi
from 91732
Fort Bragg, NC
Do NSAIDS or Executing Exercise Decrease Local Erythema, Site Swelling & Pain After INoculation
"Do NSAIDS or Executing Exercise Decrease Local Erythema, Site Swelling & Pain After INoculation: the NEED LESS PAIN Study"
Status: Enrolling
Updated: 12/31/1969
Womack Army Medical Center
2205
mi
from 91732
Fort Bragg, NC
Click here to add this to my saved trials
Do NSAIDS or Executing Exercise Decrease Local Erythema, Site Swelling & Pain After INoculation
"Do NSAIDS or Executing Exercise Decrease Local Erythema, Site Swelling & Pain After INoculation: the NEED LESS PAIN Study"
Status: Enrolling
Updated:  12/31/1969
Walter Reed National Military Medical Center
2277
mi
from 91732
Bethesda, MD
Do NSAIDS or Executing Exercise Decrease Local Erythema, Site Swelling & Pain After INoculation
"Do NSAIDS or Executing Exercise Decrease Local Erythema, Site Swelling & Pain After INoculation: the NEED LESS PAIN Study"
Status: Enrolling
Updated: 12/31/1969
Walter Reed National Military Medical Center
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Evaluation of Safety and Efficacy of Micro-coring Device for Treatment of Facial Wrinkles and Skin Laxity
A Prospective, Multi-center, Randomized Pilot Study for the Safety and Efficacy of a GEN II Micro-coring Device for the Treatment of Wrinkles and Skin Laxity in the Pre-auricular Area and Mid to Lower Face
Status: Enrolling
Updated:  12/31/1969
Laser & Skin Center of Northern CA
364
mi
from 91732
Sacramento, CA
Evaluation of Safety and Efficacy of Micro-coring Device for Treatment of Facial Wrinkles and Skin Laxity
A Prospective, Multi-center, Randomized Pilot Study for the Safety and Efficacy of a GEN II Micro-coring Device for the Treatment of Wrinkles and Skin Laxity in the Pre-auricular Area and Mid to Lower Face
Status: Enrolling
Updated: 12/31/1969
Laser & Skin Center of Northern CA
364
mi
from 91732
Sacramento, CA
Click here to add this to my saved trials
Evaluation of Safety and Efficacy of Micro-coring Device for Treatment of Facial Wrinkles and Skin Laxity
A Prospective, Multi-center, Randomized Pilot Study for the Safety and Efficacy of a GEN II Micro-coring Device for the Treatment of Wrinkles and Skin Laxity in the Pre-auricular Area and Mid to Lower Face
Status: Enrolling
Updated:  12/31/1969
SkinCare Physicians
2471
mi
from 91732
Chestnut Hill, MA
Evaluation of Safety and Efficacy of Micro-coring Device for Treatment of Facial Wrinkles and Skin Laxity
A Prospective, Multi-center, Randomized Pilot Study for the Safety and Efficacy of a GEN II Micro-coring Device for the Treatment of Wrinkles and Skin Laxity in the Pre-auricular Area and Mid to Lower Face
Status: Enrolling
Updated: 12/31/1969
SkinCare Physicians
2471
mi
from 91732
Chestnut Hill, MA
Click here to add this to my saved trials
Evaluation of Safety and Efficacy of Micro-coring Device for Treatment of Facial Wrinkles and Skin Laxity
A Prospective, Multi-center, Randomized Pilot Study for the Safety and Efficacy of a GEN II Micro-coring Device for the Treatment of Wrinkles and Skin Laxity in the Pre-auricular Area and Mid to Lower Face
Status: Enrolling
Updated:  12/31/1969
Laser & Skin Surgery Center of NY
213
mi
from 91732
New York, NY
Evaluation of Safety and Efficacy of Micro-coring Device for Treatment of Facial Wrinkles and Skin Laxity
A Prospective, Multi-center, Randomized Pilot Study for the Safety and Efficacy of a GEN II Micro-coring Device for the Treatment of Wrinkles and Skin Laxity in the Pre-auricular Area and Mid to Lower Face
Status: Enrolling
Updated: 12/31/1969
Laser & Skin Surgery Center of NY
213
mi
from 91732
New York, NY
Click here to add this to my saved trials
Evaluation of Safety and Efficacy of Micro-coring Device for Treatment of Facial Wrinkles and Skin Laxity
A Prospective, Multi-center, Randomized Pilot Study for the Safety and Efficacy of a GEN II Micro-coring Device for the Treatment of Wrinkles and Skin Laxity in the Pre-auricular Area and Mid to Lower Face
Status: Enrolling
Updated:  12/31/1969
Nashville Center for Laser and Facial Surgery
1763
mi
from 91732
Nashville, TN
Evaluation of Safety and Efficacy of Micro-coring Device for Treatment of Facial Wrinkles and Skin Laxity
A Prospective, Multi-center, Randomized Pilot Study for the Safety and Efficacy of a GEN II Micro-coring Device for the Treatment of Wrinkles and Skin Laxity in the Pre-auricular Area and Mid to Lower Face
Status: Enrolling
Updated: 12/31/1969
Nashville Center for Laser and Facial Surgery
1763
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Evaluation of Safety and Efficacy of Micro-coring Device for Treatment of Facial Wrinkles and Skin Laxity
A Prospective, Multi-center, Randomized Pilot Study for the Safety and Efficacy of a GEN II Micro-coring Device for the Treatment of Wrinkles and Skin Laxity in the Pre-auricular Area and Mid to Lower Face
Status: Enrolling
Updated:  12/31/1969
Dr A Jay Burns Cosmetic Surgery
1224
mi
from 91732
Dallas, TX
Evaluation of Safety and Efficacy of Micro-coring Device for Treatment of Facial Wrinkles and Skin Laxity
A Prospective, Multi-center, Randomized Pilot Study for the Safety and Efficacy of a GEN II Micro-coring Device for the Treatment of Wrinkles and Skin Laxity in the Pre-auricular Area and Mid to Lower Face
Status: Enrolling
Updated: 12/31/1969
Dr A Jay Burns Cosmetic Surgery
1224
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Providence Clinical Research
22
mi
from 91732
North Hollywood, CA
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Providence Clinical Research
22
mi
from 91732
North Hollywood, CA
Click here to add this to my saved trials
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Havana Research Institute
9
mi
from 91732
Pasadena, CA
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Havana Research Institute
9
mi
from 91732
Pasadena, CA
Click here to add this to my saved trials
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Vital Pharma Research Inc.
2314
mi
from 91732
Hialeah, FL
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Vital Pharma Research Inc.
2314
mi
from 91732
Hialeah, FL
Click here to add this to my saved trials
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Solutions Through Advanced Research Inc.
2130
mi
from 91732
Jacksonville, FL
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Solutions Through Advanced Research Inc.
2130
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Integrity Research Center
2322
mi
from 91732
Miami, FL
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Integrity Research Center
2322
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Millennium Clinical Research, INC
2320
mi
from 91732
Miami, FL
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Millennium Clinical Research, INC
2320
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regenerate Clinical Trials
2322
mi
from 91732
Miami, FL
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regenerate Clinical Trials
2322
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Life Medical Center & Research, Inc
2314
mi
from 91732
Miami, FL
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Life Medical Center & Research, Inc
2314
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Vista Health Research, LLC
2315
mi
from 91732
Miami, FL
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Vista Health Research, LLC
2315
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Elias Research
1831
mi
from 91732
Troy, MI
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Elias Research
1831
mi
from 91732
Troy, MI
Click here to add this to my saved trials
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Montana Medical Research/Elias Research Assoc.
909
mi
from 91732
Missoula, MT
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Montana Medical Research/Elias Research Assoc.
909
mi
from 91732
Missoula, MT
Click here to add this to my saved trials
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
L&C Professional Medical Research Institute
2329
mi
from 91732
Hazleton, PA
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
L&C Professional Medical Research Institute
2329
mi
from 91732
Hazleton, PA
Click here to add this to my saved trials
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Sun Research Institute
1189
mi
from 91732
San Antonio, TX
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Sun Research Institute
1189
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1784
mi
from 91732
Birmingham, AL
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1784
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
327
mi
from 91732
Fremont, CA
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
327
mi
from 91732
Fremont, CA
Click here to add this to my saved trials
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
13
mi
from 91732
Fullerton, CA
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
13
mi
from 91732
Fullerton, CA
Click here to add this to my saved trials
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2476
mi
from 91732
Shelton, CT
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2476
mi
from 91732
Shelton, CT
Click here to add this to my saved trials
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2309
mi
from 91732
Boynton Beach, FL
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2309
mi
from 91732
Boynton Beach, FL
Click here to add this to my saved trials
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2321
mi
from 91732
Miami, FL
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2314
mi
from 91732
Miramar, FL
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2314
mi
from 91732
Miramar, FL
Click here to add this to my saved trials
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2184
mi
from 91732
Sanford, FL
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2184
mi
from 91732
Sanford, FL
Click here to add this to my saved trials
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2131
mi
from 91732
Savannah, GA
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2131
mi
from 91732
Savannah, GA
Click here to add this to my saved trials
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1712
mi
from 91732
Oakbrook Terrace, IL
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1712
mi
from 91732
Oakbrook Terrace, IL
Click here to add this to my saved trials
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1715
mi
from 91732
Evansville, IN
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1715
mi
from 91732
Evansville, IN
Click here to add this to my saved trials
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1648
mi
from 91732
Metairie, LA
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1648
mi
from 91732
Metairie, LA
Click here to add this to my saved trials
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2275
mi
from 91732
Rockville, MD
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2275
mi
from 91732
Rockville, MD
Click here to add this to my saved trials
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1935
mi
from 91732
Bay City, MI
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Randomized, Double-Blind Study to Compare the Efficacy, Safety and Long-Term Safety of Topical Administration of FMX-101 for 1 Year in the Treatment of Moderate-to-Severe Acne Vulgaris, Study FX2014-04
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1935
mi
from 91732
Bay City, MI
Click here to add this to my saved trials